Pearl Lee
Cancer Research Institute(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors
Most-Cited Works
- → Cellular adaptation to hypoxia through hypoxia inducible factors and beyond(2020)1,175 cited
- → Modulating the therapeutic response of tumours to dietary serine and glycine starvation(2017)604 cited
- → FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome(2020)199 cited
- → HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells(2008)186 cited
- → TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis(2013)183 cited
- → Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity(2018)133 cited
- → Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestine(2015)106 cited
- → Targeting glutamine metabolism slows soft tissue sarcoma growth(2020)98 cited
- → Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients(2020)96 cited
- → TIGAR, TIGAR, burning bright(2014)96 cited